Guest guest Posted March 30, 2003 Report Share Posted March 30, 2003 [sent blindcopy] The only part of the University of California that seems to know about Lyme disease is their patent office. Enclosed below is the text from webpages for the University of California Office of Technology Transfer (OTT) that relate to four Lyme-related patents. The UC webpages describe Lyme disease as a " debilitating illness " and emphasize the " difficulty in diagnosing infection. " The reader is told that " [w]ith thousands of Lyme disease cases being reported annually in the United States, there is a SUBSTANTIAL MARKET FOR IMPROVED VACCINES AND DIAGNOSTIC AGENTS. " One would also think there would be a " SUBSTANTIAL MARKET " for TREATMENT and MEDICAL CARE for the illness, but that seems lost on the doctors and administrators within the University of California system. The UCSF previously had a Lyme disease clinic that was operated under Dick s, MD, but it was closed. At present, patients in the California Lyme disease patient support groups can vouch for the fact that care for tick-borne disease is not available at UC medical centers. Seems the only market that UC cares about is that of vaccines and diagnostics. When I was at UCSF on Friday for a scan in the Radiology Department, a nurse told me all about her own inability to get medical care for Lyme disease at UCSF when she became ill with Lyme disease in 1996. The nurse repeatedly called Dick s, MD (UCSF infectious disease specialist) an " asshole, " and described how she told Dr. s of her rash and had saved the tick. Even though she was ill with symptoms consistent with Lyme disease, Dr. s refused to test the tick. " There is no Lyme disease in California! " he said. The nurse described how she became more and more ill because she received no treatment, and how it impaired her recovery. The nurse described a child who was ill who also had denied treatment at UCSF. Afterwards, I thought I should do what was logical under these circumstances, and stopped by the Patient Relations Department to find out how I could file a complaint. Certainly, if we received such inferior care in any other respect, we would be calling and writing the patient complaints office or even visiting attorneys. Why do we accept this situation with respect to tick-borne disease? I described the problem to a of the Patient Relations Department. Listening to the story, she correctly surmised this is a systemic problem. Ms. suggested that I contact two UCSF administrators: Chancellor Bishop Chancellor's Office Box 0402 513 Parnassus Ave, Suite 126 San Francisco, CA Tel. (415) 476-2401 Fax (415) 476-9634 Email: <A HREF= " mailto:jmbishop@... " >jmbishop@...</A> Mark R. Laret CEO, UCSF Medical Center Medical Center Administration Box 0296, MU 509E 500 Parnassus Ave. San Francisco, CA 94143 Tel. (415) 353-2733 Fax (415) 353-2765 Email: mark.laret@... Tonight, I spoke with Jim Katzel, MD who used to work as a physician in the UCSF Lyme disease clinic. Dr. Katzel said he worked there for five years, but the commute back and forth from Mendocino County was too difficult. He said his boss was s, MD, and that it was s, MD who recruited him to work in the UCSF Lyme disease clinic. Dr. Katzel said the Lyme disease clinic at UCSF was very busy during the time it was open. He could not estimate how many patients were followed in the clinic. Dr. Katzel said that when he left, Dr. s was supposed to manage the patients who remained in the clinic. He did not mention that any of the patients were referred elsewhere. What happened to all of the patients who were in the clinic? Last winter, I felt extremely ill, and tried and tried to get an appointment with Dr. s. I faxed and telephoned him repeatedly, but he would never approve an appointment for me to see him. The faxes contained detailed information about my history of tick-borne disease, including positive lab tests, and information about my current symptoms. The symptoms have been so severe that I have not been able to work. After all my efforts, I simply gave up. I told Dr. Katzel of the difficulty I am experiencing finding medical care, and that I did not understand why patients cannot receive care for this endemic disease at UCSF. I had never heard of any medical center ever turning patients away for treatment of any other medical condition. What -- the medical center " doesn't do " certain kinds of brain tumors? They don't do " heart disease " ? They " don't do " malaria? I am weary of people telling me to go see Dr. " X, " " Y, " or " Z " whom I know, being a physician myself, is not qualified to treat a complicated infectious disease patient who has other major medical problems (i,.e., myself), or that I should get on an airplane and fly 3000 miles away, or that I should be treated via telephone by a doctor in another state, or on the East Coast -- and that their suggestion is supposed to be a solution. Are you KIDDING??? Here are some of the UC webpages about their Lyme-related patents. The University of California *knows* about Lyme disease -- hey, they see it as a moneymaker -- a potential revenue stream -- but it is another issue of trying to get care within their hospital walls. Lynn Shepler, MD JD Mountain View, CA ----------------------------------- <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe " >Click here: NCD Search Results</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe " >http://patron.ucop.edu/sea\ rch97cgi/s97_cgi.exe</A> NCD Search Result Your query Lyme matched 4 out of 1385 documents, shown below. Title/URL <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cuci%2E2000%2D414%2D1%2Ehtml & DocOffset=1 & DocsFound=4 & Que\ ryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fp\ atron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26ResultMax\ Docs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultField%3\ DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Collecti\ on%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCount%3\ D100 & " >1. A Tick Cytokine For Vaccines And Immunomodulation</A> (highlighted) <A HREF= " http://patron.ucop.edu/ncd/docs/uci.2000-414-1.html " >http://patron.ucop.ed\ u/ncd/docs/uci.2000-414-1.html</A> (original) 2602 bytes Last modified 19-Dec-2000 08:09:54 pm <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E2000%2D201%2D0%2E00%2Ehtml & DocOffset=2 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >2. ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS</A> (highlighted) <A HREF= " http://patron.ucop.edu/ncd/docs/ott.2000-201-0.00.html " >http://patron.ucop\ ..edu/ncd/docs/ott.2000-201-0.00.html</A> (original) 3527 bytes Last modified 28-Mar-2003 07:34:05 pm <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1996%2D559%2D0%2E00%2Ehtml & DocOffset=3 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >3. ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS</A> (highlighted) <A HREF= " http://patron.ucop.edu/ncd/docs/ott.1996-559-0.00.html " >http://patron.ucop\ ..edu/ncd/docs/ott.1996-559-0.00.html</A> (original) 3807 bytes Last modified 28-Mar-2003 07:32:49 pm <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1990%2D017%2D0%2E00%2Ehtml & DocOffset=4 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >4. LYME DISEASE ASSAY</A> (highlighted) <A HREF= " http://patron.ucop.edu/ncd/docs/ott.1990-017-0.00.html " >http://patron.ucop\ ..edu/ncd/docs/ott.1990-017-0.00.html</A> (original) 4247 bytes Last modified 28-Mar-2003 07:30:39 pm ------------------------------------------------------------------------------ ------------- <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cuci%2E2000%2D414%2D1%2Ehtml & DocOffset=1 & DocsFound=4 & Que\ ryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fp\ atron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26ResultMax\ Docs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultField%3\ DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Collecti\ on%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCount%3\ D100 & " >Click here: A Tick Cytokine For Vaccines And Immunomodulation</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cuci%2E2000%2D414%2D1%2Ehtml & DocOffset=1 & DocsFound=4 & Que\ ryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fp\ atron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26ResultMax\ Docs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultField%3\ DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Collecti\ on%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCount%3\ D100 & " >http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%5Cwwwroot%5Cncd%5Cdocs%5Cuci%2E2000%2D414%2D1%2Ehtml & DocOffset=1 & DocsFound=4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQ ueryZip%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultF ield%3DTitle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize %26QueryText%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%2 6ResultStart%3D1%26ResultCount%3D100 & </A> Technology/Business Opportunity Non-Confidential Executive Summary UC CASE NUMBER: 2000-414-1 TITLE: A Tick Cytokine For Vaccines And Immunomodulation DEPARTMENT: Microbiology & Molecular Genetics SUMMARY: Ticks can transmit disease to humans, pets and livestock. It is well known that ticks can carry Lyme disease, which is caused by a pathogenic bacterium living in the gut of the tick. An approach to dealing with tick-related diseases is the development of vaccines against the ticks themselves. Researchers at the University of California, Irvine have developed a system which includes characterizing the gut of the tick on a genetic and protein level, creating recombinant proteins and antigens to those proteins and using those antigens for the development of an anti-tick vaccine. This proccess has wide ranging application in both the biomedical field and livestock management. CONTACT: Vithal Rajadhyaksha - UCI Email: <A HREF= " mailto:vjrajadh@...%3Fsubject=Request%20for%20Information%20for%20Case\ %20No.2000-414-1 " >vjrajadh@...</A> Office of Technology Alliances University of California 380 University Tower Irvine, CA 92697-7700 Telephone: (949) 824-7295 Fax: (949) 824-2899 --------------------------------------------------------------------- <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E2000%2D201%2D0%2E00%2Ehtml & DocOffset=2 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >Click here: ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E2000%2D201%2D0%2E00%2Ehtml & DocOffset=2 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%5Cwwwroot%5Cncd%5Cdocs%5Cott%2E2000%2D201%2D0%2E00%2Ehtml & DocOffset=2 & DocsFound=4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQ ueryZip%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultF ield%3DTitle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize %26QueryText%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%2 6ResultStart%3D1%26ResultCount%3D100 & </A> Non-Confidential Description ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS The tick-borne organism responsible for Lyme disease, Borrelia burgodorferi, produces a lipoprotein that serves as an antigen for the existing Lyme disease vaccine. However, this vaccine has limited efficacy, mainly due to downregulation of the lipoprotein while B. burgodorferi is present in a mammalian host. A further problem in treating Lyme disease is the current difficulty in diagnosing infections. Thus, there is a pressing need for B. burgodorferi antigens that would more efficiently single out B. burgodorferi within mammalian hosts. University of California researchers have isolated and characterized three outer membrane-spanning proteins from B. burgodorferi which have the potential to serve as targets for immunoprotective and/or diagnostic antibodies, offering a promising alternative to the lipoprotein. The researchers also confirmed that one of the UC proteins elicits immunoprotective responses in laboratory mice, thus showing that these proteins are likely to lead to greatly improved vaccines and diagnostic reagents (e.g. for serodiagnostic kits) against Lyme disease. Because of the localized concentration of the disease in certain geographic regions, use of diagnostic and therapeutic agents derived from this invention would be particularly attractive given the existence of readily identifiable populations of at-risk humans and animals. With thousands of Lyme disease cases being reported annually in the United States, there is a substantial market for improved vaccines and diagnostic agents. INQUIRIES TO: Bernadette McCafferty <A HREF= " mailto:bernadette.mccafferty@... " >bernadette.mccafferty@...</A> REFERENCE: 2000-201 RELATED CASES: 1996-559 <A HREF= " http://patron.ucop.edu/ncd/techcodes/toplevel.html " >Technology Categories</A> Pharmaceuticals > Serums & related agents > Vaccines University of California Office of Technology Transfer 1111 lin Street, Fifth Floor Oakland, CA 94607-5200 Phone: (510) 587-6000 Fax: (510) 587-6090 Go to <A HREF= " http://www.ucop.edu/ott/faculty.html " >Faculty Guidance</A> Go to <A HREF= " http://www.ucop.edu/ott/industry.html " >UC Bridges to Industry</A> Go to <A HREF= " http://www.ucop.edu/ott/admin.html " >Resources for Administrators</A> © Copyright 1996 The Regents of the University of California. All Rights Reserved. <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?QueryZip=Lyme & ResultMaxDocs\ =1000 & ResultTemplate=ncd%2Ehts & ResultField=Title & ResultField=URL & ResultField=Mod\ ified & ResultField=Size & QueryText=Lyme & Collection=NCD & SortField=Title & SortOrder=A\ sc & ResultStart=1 & ResultCount=100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[G\ o Back To Results]</A> & AdminImagePath= " >[Previous Doc]</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=Viewe%26SortOrder%3D\ Asc%26ResultStart%3D1%26ResultCount%3D100 & AdminScriptName= & ServerKey= & AdminImage\ Path= " >[Next Doc]</A> ------------------------------------------------------------------------------- <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1996%2D559%2D0%2E00%2Ehtml & DocOffset=3 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >Click here: ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1996%2D559%2D0%2E00%2Ehtml & DocOffset=3 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1996%2D559%2D0%2E00%2Ehtml & DocOffset=3 & DocsFound=4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQ ueryZip%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultF ield%3DTitle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize %26QueryText%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%2 6ResultStart%3D1%26ResultCount%3D100 & </A> Non-Confidential Description ANTIGENS FOR IMPROVED LYME DISEASE VACCINES AND DIAGNOSTIC REAGENTS The tick-borne organism responsible for Lyme disease, Borrelia burgodorferi, produces a lipoprotein that serves as an antigen for the existing Lyme disease vaccine. However, this vaccine has limited efficacy, mainly due to downregulation of the lipoprotein while B. burgodorferi is present in a mammalian host. A further problem in treating Lyme disease is the current difficulty in diagnosing infections. Thus, there is a pressing need for B. burgodorferi antigens that would more efficiently single out B. burgodorferi within mammalian hosts. University of California researchers have isolated and characterized three outer membrane-spanning proteins from B. burgodorferi which have the potential to serve as targets for immunoprotective and/or diagnostic antibodies, offering a promising alternative to the lipoprotein. The researchers also confirmed that one of the UC proteins elicits immunoprotective responses in laboratory mice, thus showing that these proteins are likely to lead to greatly improved vaccines and diagnostic reagents (e.g. for serodiagnostic kits) against Lyme disease. Because of the localized concentration of the disease in certain geographic regions, use of diagnostic and therapeutic agents derived from this invention would be particularly attractive given the existence of readily identifiable populations of at-risk humans and animals. With thousands of Lyme disease cases being reported annually in the United States, there is a substantial market for improved vaccines and diagnostic agents. INQUIRIES TO: Bernadette McCafferty <A HREF= " mailto:bernadette.mccafferty@... " >bernadette.mccafferty@...</A> REFERENCE: 1996-559 RELATED CASES: 2000-201 PATENT STATUS: US Patent # <A HREF= " http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1 & Sect2=HITOFF & d=PALL & p\ =1 & u=/netahtml/srchnum.htm & r=1 & f=G & l=50 & s1='6,153,194'.WKU. & OS=PN/6,153,194 & RS=P\ N/6,153,194 " >6,153,194</A> issued November 28, 2000 <A HREF= " http://patron.ucop.edu/ncd/techcodes/toplevel.html " >Technology Categories</A> Pharmaceuticals > Serums & related agents > Vaccines University of California Office of Technology Transfer 1111 lin Street, Fifth Floor Oakland, CA 94607-5200 Phone: (510) 587-6000 Fax: (510) 587-6090 Go to <A HREF= " http://www.ucop.edu/ott/faculty.html " >Faculty Guidance</A> Go to <A HREF= " http://www.ucop.edu/ott/industry.html " >UC Bridges to Industry</A> Go to <A HREF= " http://www.ucop.edu/ott/admin.html " >Resources for Administrators</A> © Copyright 1996 The Regents of the University of California. All Rights Reserved. <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?QueryZip=Lyme & ResultMaxDocs\ =1000 & ResultTemplate=ncd%2Ehts & ResultField=Title & ResultField=URL & ResultField=Mod\ ified & ResultField=Size & QueryText=Lyme & Collection=NCD & SortField=Title & SortOrder=A\ sc & ResultStart=1 & ResultCount=100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[G\ o Back To Results]</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & Collection=NCD & \ QueryZip=Lyme & SortSpec=Score+Desc & SortOrder=Asc & SortField=Title & DocOffset=2 & Sear\ chUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZi\ p%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DT\ itle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryTe\ xt%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart\ %3D1%26ResultCount%3D100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[Previous Doc]</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & Collection=NCD & \ QueryZip=Lyme & SortSpec=Score+Desc & SortOrder=Asc & SortField=Title & DocOffset=4 & Sear\ chUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZi\ p%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DT\ itle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryTe\ xt%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart\ %3D1%26ResultCount%3D100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[Next Doc]</A> ------------------------------------------------------------------------------ ----- <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1990%2D017%2D0%2E00%2Ehtml & DocOffset=4 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >Click here: LYME DISEASE ASSAY</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%\ 5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1990%2D017%2D0%2E00%2Ehtml & DocOffset=4 & DocsFound=\ 4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2\ F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZip%3DLyme%26Resu\ ltMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DTitle%26ResultFi\ eld%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryText%3DLyme%26Col\ lection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart%3D1%26ResultCo\ unt%3D100 & " >http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & VdkVgwKey=f%3A%5Cwwwroot%5Cncd%5Cdocs%5Cott%2E1990%2D017%2D0%2E00%2Ehtml & DocOffset=4 & DocsFound=4 & QueryZip=Lyme & Collection=NCD & SortField=Title & SortOrder=Asc & SearchUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQ ueryZip%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultF ield%3DTitle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize %26QueryText%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%2 6ResultStart%3D1%26ResultCount%3D100 & </A> Non-Confidential Description LYME DISEASE ASSAY Lyme disease is a debilitating illness whose etiological agent, the bacteria Borrelia burgdoferi, is transmitted by tick bites. Early antibiotic treatment is important for preventing the severe consequences of the later stages of infection, which can include arthritis, heart disorders, and various neurological dysfunctions. However, the disease is often not identified early enough, as initial symptoms of the disease such as headaches, rashes, and inflammation are easily misdiagnosed. Currently available Lyme disease diagnostic kits lack adequate specificity and sensitivity, thus creating a need for better detection methods. It is estimated that a superior diagnostic kit would command a market of 0.5 million to 1.0 million tests per year in the United States. University of California scientists have cloned a surface antigen gene from B. burgdoferi that provokes a strong immune response (both IgM and IgG) in serum from humans and other mammals. This gene can serve as a basis for antibody screens and nucleic acid probes. The UC gene, in an appropriate recombinant vector, could produce large quantities of antigenic proteins suitable for specific detection of anti-Lyme antibodies. Antibody assays with these antigens eliminates the background and cross-reactivity problems normally encountered when B. burgdoferi whole cell isolates are used as a substrate for screening antibodies, as in current diagnostic systems. Nucleic acid probes based on this gene will also have significant diagnostic uses, particularly in testing Lyme patients following treatment to assess whether or not the disease organism has been successfully eradicated. Prospects for the large-scale employment of the UC gene in Lyme diagnostic applications are considered quite strong in light of the considerable improvement in disease detection it makes possible. INQUIRIES TO: Karin Immergluck <A HREF= " mailto:karin.immergluck@... " >karin.immergluck@...</A> REFERENCE: 1990-017 PATENT STATUS: US Patent # <A HREF= " http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1 & Sect2=HITOFF & d=PALL & p\ =1 & u=/netahtml/srchnum.htm & r=1 & f=G & l=50 & s1='5,324,630'.WKU. & OS=PN/5,324,630 & RS=P\ N/5,324,630 " >5,324,630</A> issued June 28, 1994; US Patent # <A HREF= " http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1 & Sect2=HITOFF & d=PALL & p\ =1 & u=/netahtml/srchnum.htm & r=1 & f=G & l=50 & s1='5,977,339'.WKU. & OS=PN/5,977,339 & RS=P\ N/5,977,339 " > 5,977,339</A> issued November 2, 1999 <A HREF= " http://patron.ucop.edu/ncd/techcodes/toplevel.html " >Technology Categories</A> Biotechnology > Genetic engineering sys University of California Office of Technology Transfer 1111 lin Street, Fifth Floor Oakland, CA 94607-5200 Phone: (510) 587-6000 Fax: (510) 587-6090 Go to <A HREF= " http://www.ucop.edu/ott/faculty.html " >Faculty Guidance</A> Go to <A HREF= " http://www.ucop.edu/ott/industry.html " >UC Bridges to Industry</A> Go to <A HREF= " http://www.ucop.edu/ott/admin.html " >Resources for Administrators</A> © Copyright 1996 The Regents of the University of California. All Rights Reserved. <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?QueryZip=Lyme & ResultMaxDocs\ =1000 & ResultTemplate=ncd%2Ehts & ResultField=Title & ResultField=URL & ResultField=Mod\ ified & ResultField=Size & QueryText=Lyme & Collection=NCD & SortField=Title & SortOrder=A\ sc & ResultStart=1 & ResultCount=100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[G\ o Back To Results]</A> <A HREF= " http://patron.ucop.edu/search97cgi/s97_cgi.exe?action=View & Collection=NCD & \ QueryZip=Lyme & SortSpec=Score+Desc & SortOrder=Asc & SortField=Title & DocOffset=3 & Sear\ chUrl=http%3A%2F%2Fpatron%2Eucop%2Eedu%2Fsearch97cgi%2Fs97%5Fcgi%2Eexe%3FQueryZi\ p%3DLyme%26ResultMaxDocs%3D1000%26ResultTemplate%3Dncd%252Ehts%26ResultField%3DT\ itle%26ResultField%3DURL%26ResultField%3DModified%26ResultField%3DSize%26QueryTe\ xt%3DLyme%26Collection%3DNCD%26SortField%3DTitle%26SortOrder%3DAsc%26ResultStart\ %3D1%26ResultCount%3D100 & AdminScriptName= & ServerKey= & AdminImagePath= " >[Previous Doc]</A> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 31, 2003 Report Share Posted March 31, 2003 Lynn, it is great you are checking into all this. It is indeed a travesty and there are many forces behind it (as I've said on lyement), vaccines being only one piece of the puzzle--there is also just the inertia of medicine, the punishment one gets for stepping outside the mainstream as a doctor, the turfing of diseases and " academic apartheid " , tourism interests which would be devastated if anyone knew how endemic lyme was in certain places, pharmaceutical interests (after all, our pharmas are so powerful that Bush vetoed an international agreement to give meds cheaply to poor countries). On the other hand, if you have to travel to be treated, then that's the way it is & you should do it to get excellent care. In the greater scheme of things, you are in a country where treatment IS available and you probably can afford it. That is better than being in a country where you are dying for lack of meds that won't be sold at a reseonable cost, and are nowhere to be found. You need to get well as much as you need to fight the system (if you choose to fight the system). Just my opinion, and glad you are looking into all this. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.